What Makes CBOE Global (CBOE) a Strong Momentum Stock: Buy Now?

Zacks highlights CBOE Global as a momentum buy, assigning a Momentum Style Score of A and a Zacks Rank #2 (Buy). Shares have risen 2.21% over the past week, 3.39% over the past month, 8.92% over the past quarter and 20.47% over the last year, with a 20-day average volume of 717,597 shares. Analysts have revised earnings estimates materially higher in the past 60 days — full‑year consensus moved from $9.66 to $10.15 with 10 upward revisions and none downward, and nine upward revisions for the next fiscal year — supporting the bullish thesis. Zacks concludes CBOE is positioned for near‑term upside based on price momentum and positive estimate revisions.

Analysis

Market structure: Rising estimates and momentum for CBOE (CBOE) signal continued demand for options/volatility products versus plain-vanilla cash equity trading; direct winners are exchanges, clearinghouses and market-data vendors, while low-fee lit venues and some retail brokers (who earn less per trade) could see margin pressure. If options ADV and notional trading grows 5-10% year-over-year, CBOE captures outsized revenue through fee-for-service and VIX-linked product expansion, preserving gross margins near current levels.

Risk assessment: Key tails are regulatory action on market-data/fee unbundling or a severe collapse in volatility (VIX -50%+ from peak) that would cut transaction revenue; operational outages on days of market stress could incur fines and client flight. Immediate (days) risk is momentum reversal; short-term (weeks–months) depends on earnings-execution and realized volumes; long-term (quarters–years) centers on product diversification and fee compression from competitors or regulators.

Trade implications: Favor a modest long allocation to CBOE while hedging macro-volatility exposure; use directional equity plus options to control downside. Cross-asset, anticipate positive correlation with realized volatility and VIX futures — consider VIX call spreads as asymmetric hedges if macro tail-risk rises; rotate 1–3% AUM from low-growth fintech into exchange equities and market-data vendors over next 1–3 quarters.

Contrarian angles: Consensus momentum misses fee-pressure risk and potential regulatory headlines (SEC/CFTC) within 60–90 days; the current price run-up may underprice a 10–20% drawdown if realized volumes normalize. Historical analog: 2018 vol spike boosted exchange profits but was followed by correction when volumes normalized — plan for mean reversion rather than uninterrupted multiple expansion.

Key Decisions for Investors

• Establish a 1.5–2.5% long position in CBOE (CBOE) equity within 1–7 trading days; add a tactical 0.75–1.0% exposure via a 9–12 month call spread (10–15% OTM) to cap cost and retain ~3x upside if estimates hold; trim all CBOE exposure if forward earnings revisions fall >5% within 60 days.
• Enter a relative-value pair: long CBOE (1%) vs short ICE (ICE) (0.75%) sized to beta-neutrality over 3–6 months — rationale: CBOE benefits more from retail/options-adjacent flows and VIX product growth; close if the spread narrows by 25% or if ICE issues guidance >CBOE by >5%.
• Buy a VIX calendar call spread (near-term expiry vs 3–6 month expiry) sized to 0.5% AUM as tail-risk insurance if macro volatility rises; target payoff if VIX spikes +30% from current levels, close if realized vol remains <10% above already-implied levels after 30 days.
• Reduce exposure by 1–2% to lower-growth market-data/subscription fintech names and redeploy into exchanges/market-data leaders if CBOE posts +5% beat on EPS or ADV growth >7% in next quarterly report.
• Monitor SEC/CFTC notices and any market-data fee proposals over the next 30–60 days: if a proposal caps or forces unbundling that projects >5% revenue hit to exchanges, liquidate >50% of CBOE position within 5 trading days of final rule announcement.